The additional MMR/HRR mutations we could detect in our MLH1-/PMS2-/MSH6- cases could play a mechanistic role in the loss of MSH6 expression in already MLH1/PMS2-deficient digestive system cancers by paving the way for further mutations in the MSH6 gene. This evidence concerns the gene MLH1 and digestive system cancer.